Study of QMF149 (150/80 µg) Compared With MF Twisthaler® (200 µg) in Patients With Asthma

PHASE3CompletedINTERVENTIONAL
Enrollment

802

Participants

Timeline

Start Date

January 16, 2017

Primary Completion Date

November 5, 2018

Study Completion Date

November 30, 2018

Conditions
Mild Asthma
Interventions
DRUG

QMF149 150/80 μg

QMF149 150/80 μg o.d via Concept1

DRUG

MF 200 μg

MF 200 μg o.d. via Twisthaler®

Trial Locations (122)

10

Novartis Investigative Site, Lima

14

Novartis Investigative Site, Lima

33

Novartis Investigative Site, Santiago de Surco

84

Novartis Investigative Site, Cusco

1008

Novartis Investigative Site, Manila

1011

Novartis Investigative Site, Riga

1050

Novartis Investigative Site, Middelburg

1100

Novartis Investigative Site, Quezon City

2000

Novartis Investigative Site, Piura

2045

Novartis Investigative Site, Törökbálint

2100

Novartis Investigative Site, Gödöllő

2440

Novartis Investigative Site, Százhalombatta

2700

Novartis Investigative Site, Cegléd

5000

Novartis Investigative Site, Iloilo City

5540

Novartis Investigative Site, Szarvas

5800

Novartis Investigative Site, Pleven

6000

Novartis Investigative Site, Stara Zagora

6722

Novartis Investigative Site, Szeged

7530

Novartis Investigative Site, Belleville

7531

Novartis Investigative Site, Cape Town

7550

Novartis Investigative Site, Panorama

7570

Novartis Investigative Site, Cape Town

8109

Novartis Investigative Site, Vilnius

8340

Novartis Investigative Site, Winnie Mandela

9024

Novartis Investigative Site, Győr

10119

Novartis Investigative Site, Berlin

10400

Novartis Investigative Site, Bangkok

13419

Novartis Investigative Site, Tallinn

14068

Novartis Investigative Site, Anyang-si

14584

Novartis Investigative Site, Bucheon-si

16147

Novartis Investigative Site, Genova

16499

Novartis Investigative Site, Suwon

18450

Novartis Investigative Site, Hwaseong-si

20354

Novartis Investigative Site, Hamburg

20400

Novartis Investigative Site, Kuala Terengganu

23552

Novartis Investigative Site, Lübeck

30173

Novartis Investigative Site, Hanover

30322

Novartis Investigative Site, Kohtla-Järve

34000

Novartis Investigative Site, Taiping

40002

Novartis Investigative Site, Khon Kaen

44791

Novartis Investigative Site, Bochum

50134

Novartis Investigative Site, Florence

50200

Novartis Investigative Site, Chiang Mai

51014

Novartis Investigative Site, Tartu

55131

Novartis Investigative Site, Mainz

60596

Novartis Investigative Site, Frankfurt

62250

Novartis Investigative Site, Putrajaya

64283

Novartis Investigative Site, Darmstadt

70020

Novartis Investigative Site, Cassano delle Murge

75237

Novartis Investigative Site, Uppsala

82131

Novartis Investigative Site, Gauting

86825

Novartis Investigative Site, Bad Wörishofen

86899

Novartis Investigative Site, Landsberg

110911

Novartis Investigative Site, Bogota

115478

Novartis Investigative Site, Moscow

157006

Novartis Investigative Site, Setagaya-ku

180000

Novartis Investigative Site, Haiphong

191015

Novartis Investigative Site, Saint Petersburg

194044

Novartis Investigative Site, Saint Petersburg

196240

Novartis Investigative Site, Saint Petersburg

221005

Novartis Investigative Site, Varanasi

334003

Novartis Investigative Site, Bikaner

344011

Novartis Investigative Site, Rostov-on-Don

390022

Novartis Investigative Site, Vadodara

401107

Novartis Investigative Site, Mumbai

500018

Novartis Investigative Site, Hyderabad

560099

Novartis Investigative Site, Bangalore

570001

Novartis Investigative Site, Mysore

580022

Novartis Investigative Site, Hubli

620028

Novartis Investigative Site, Yekaterinburg

688524

Novartis Investigative Site, Cherthala

700000

Novartis Investigative Site, Ho Chi Minh City

2520594

Novartis Investigative Site, Viña del Mar

7500692

Novartis Investigative Site, Santiago

8380453

Novartis Investigative Site, Santiago

Unknown

Novartis Investigative Site, Bulgaria

Novartis Investigative Site, Santiago

Novartis Investigative Site, Bogotá

Novartis Investigative Site, Bucaramanga

Novartis Investigative Site, Medellín

Novartis Investigative Site, Nagpur

0050010

Novartis Investigative Site, Medellín

04207

Novartis Investigative Site, Leipzig

D-35037

Novartis Investigative Site, Marburg

380 060

Novartis Investigative Site, Ahmedabad

641 045

Novartis Investigative Site, Coimbatore

00054

Novartis Investigative Site, Fiumicino

00161

Novartis Investigative Site, Roma

103 0027

Novartis Investigative Site, Chuo Ku

103-0027

Novartis Investigative Site, Chuo-ku

162-0053

Novartis Investigative Site, Shinjuku-ku

171-0014

Novartis Investigative Site, Toshima-ku

LV-2015

Novartis Investigative Site, Jūrmala

LV-5417

Novartis Investigative Site, Daugavpils

LV 1002

Novartis Investigative Site, Riga

LV-1001

Novartis Investigative Site, Riga

LV-1004

Novartis Investigative Site, Riga

LT-08661

Novartis Investigative Site, Vilnius

05460

Novartis Investigative Site, Alor Star

15-430

Novartis Investigative Site, Biaystok

15-044

Novartis Investigative Site, Bialystok

86-300

Novartis Investigative Site, Grudziądz

40 085

Novartis Investigative Site, Katowice

085 01

Novartis Investigative Site, Bardejov

972 01

Novartis Investigative Site, Bojnice

066 01

Novartis Investigative Site, Humenné

033 01

Novartis Investigative Site, Liptovský Hrádok

052 01

Novartis Investigative Site, Spišská Nová Ves

09101

Novartis Investigative Site, Stropkov

974 05

Novartis Investigative Site, Banská Bystrica

058 01

Novartis Investigative Site, Poprad

841 04

Novartis Investigative Site, Bratislava

022 01

Novartis Investigative Site, Čadca

080 01

Novartis Investigative Site, Prešov

08301

Novartis Investigative Site, Sabinov

960 01

Novartis Investigative Site, Zvolen

03312

Novartis Investigative Site, Seoul

06591

Novartis Investigative Site, Seoul

612-896

Novartis Investigative Site, Busan

02841

Novartis Investigative Site, Seoul

111 57

Novartis Investigative Site, Stockholm

587 58

Novartis Investigative Site, Linköping

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY